Cd19/bcma-targeted car-t cells

1 paper1 finding

Outcomes

1

Long-term remission

upin humans1

1 study

Cd19/bcma-targeted car-t cells improve long-term remission in humans.
“CD19/BCMA-targeted CAR-T cells achieving long-term remission in lupus and rheumatoid arthritis without ongoing immunosuppression”
Reviewin lupus and rheumatoid arthritis
CAR-engineered cell therapies: current understandings and future perspectives
Molecular biomedicine21 Jan 2026

Latest

1 in 12 months

Molecular Biomedicine21 Jan

CAR-engineered cell therapies: current understandings and future perspectives

ReviewInterventions